ReShape Weightloss Inc.
Healthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|---|---|
| Revenue | $11.3M | $15.1M | $607,000 | $569,160 | $72,000 | $292,000 |
| Operating income | −$12.5M | −$24.5M | −$38.5M | −$28.1M | −$22.8M | −$27.9M |
| Net income | −$21.6M | −$74.2M | −$81.2M | −$33.8M | −$7.4M | −$25.5M |
| Total assets | $37.1M | $39.7M | $46.3M | $88.7M | $7.0M | $11.6M |
| Total liabilities | $22.6M | $15.5M | $14.6M | $12.3M | $4.1M | $7.9M |
| Equity | $14.5M | $24.1M | $31.7M | $76.4M | $2.9M | $3.7M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 5.5M | 8.9M | 31.0M | 6.9M | 8.1M | 73.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2020- Operating margin
- −110.2%
- Net margin
- −191.4%
- Return on equity
- −149.3%
- Return on assets
- −58.4%
- Return on capital (ROCE)
- −48.9%
- Liabilities / assets
- 60.9%
- Debt / equity
- 1.56×
- Book value / share
- $2.64
- Revenue growth (YoY)
- −25.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2020- Altman Z″ (distress)
- -47.34distress
- Accruals / assets
- −35.3%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 4 warning● 1 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.